Creative Medical Technology Inc.
CELZ | NASDAQ
$1
+$0.03 (+3.53%)
At close: Sep 21, 2026, 4:00 PM ET
$0.99
-$0.01 (-1.00%)
After-hours:
Sep 21, 2026, 7:59 PM ET
Company Profile
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Key Executives
| Name | Position |
|---|---|
| Timothy Warbington | Co-Founder, Chairman, President & Chief Executive Officer |
| Donald Dickerson | Senior Vice President, Chief Financial Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 31, 2026 | 8-K | Current Report |
| Aug 07, 2026 | 10-Q | Quarterly Report |
| Aug 03, 2026 | 424B3 | Filing |
| Jul 31, 2026 | EFFECT | Filing |
| Jul 24, 2026 | S-3 | Filing |
| Jul 14, 2026 | DEF 14A | Filing |
| Jul 02, 2026 | 8-K | Current Report |
| Jul 01, 2026 | PRE 14A | Filing |
| Jun 30, 2026 | RW | Filing |
| Jun 26, 2026 | S-1/A | [Amend] Filing |
Creative Medical Technology Inc.
| Country | United States |
| IPO Date | Nov 5, 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Timothy Warbington |
Contact Details
211 East Osborn Road Phoenix,
Arizona 85012 United States
Stock Details
| Ticker Symbol | CELZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001187953 |
| CUSIP Number | 22529Y408 |
| ISIN Number | US22529Y4089 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove CELZ